SCHOR, A.M., I.R. ELLIS, S.J. JONES, S. PERRIER, M.M. FLORENCE, J. COX, G. OHE, Kateřina KAŇKOVÁ, Bořivoj VOJTĚŠEK, A.M. THOMPSON, C. PURDIE, S. KAZMI, S. FOO, A.M. WOOLSTON and S.L. SCHOR. Identification and role of migration stimulating factor isoforms in breast carcinomas. 2008.
Other formats:   BibTeX LaTeX RIS
Basic information
Original name Identification and role of migration stimulating factor isoforms in breast carcinomas
Name in Czech Identification and role of migration stimulating factor isoforms in breast carcinomas
Authors SCHOR, A.M., I.R. ELLIS, S.J. JONES, S. PERRIER, M.M. FLORENCE, J. COX, G. OHE, Kateřina KAŇKOVÁ, Bořivoj VOJTĚŠEK, A.M. THOMPSON, C. PURDIE, S. KAZMI, S. FOO, A.M. WOOLSTON and S.L. SCHOR.
Edition 2008.
Other information
Original language English
Type of outcome Conference abstract
Field of Study 30200 3.2 Clinical medicine
Country of publisher United Kingdom of Great Britain and Northern Ireland
Confidentiality degree is not subject to a state or trade secret
Organization unit Faculty of Medicine
UT WoS 000255940900071
Keywords in English breast cancer; MSF
Tags breast cancer, MSF
Tags International impact, Reviewed
Changed by Changed by: prof. MUDr. Kateřina Kaňková, Ph.D., učo 2524. Changed: 19/3/2010 12:59.
Abstract
MSF isoforms are present in most breast tumours and are secreted by breast tumour cell lines. MSF stimulates tumour cell invasion in an autocrine and paracrine manner, modulated by the type of isoform expressed and by the presence of MSFI.
Abstract (in Czech)
MSF isoforms are present in most breast tumours and are secreted by breast tumour cell lines. MSF stimulates tumour cell invasion in an autocrine and paracrine manner, modulated by the type of isoform expressed and by the presence of MSFI.
PrintDisplayed: 24/4/2024 22:03